October 16, 2026

Positive Field Trial Results for InLiq Agri: 11.3% Higher Wheat Yield Compared with Farm Standard

We are pleased to report positive results from our latest InLiq Agri field trial in wheat in Finland.

The treatment programme including InLiq Agri delivered an 11.3% higher yield than the farm’s standard treatment programme, corresponding to approximately 1,000 kg/ha of additional adjusted yield. Compared with the untreated control, the yield was 18% higher. The adjusted yield for the InLiq Agri-containing treatment reached 9,449 kg/ha.

The results were also encouraging from a crop quality perspective. The InLiq Agri-containing treatment produced 9.6% more protein per hectare than the farm standard and 26% more than the untreated control. Milling quality was good across all treatments, with the InLiq Agri-containing treatment (277) showing the best overall milling quality.

The field trial covered approximately 3.5 hectares, with a modified replicate number of N=7. The trial compared the InLiq Agri-containing treatment with the farm’s standard treatment programme and an untreated control under practical farming conditions.

Early observations also showed the strongest root development and rhizosheath formation in the InLiq Agri-containing treatment, supporting further investigation into the early-stage effects of InLiq Agri.

The InLiq Agri-containing treatment achieved the highest dry matter yield per kg of applied nitrogen: 80 kg DM/kg N, which was 17.6% higher than the control (68 kg DM/kg N) and 11.1% higher than the standard treatment (72 kg DM/kg N).

 

Importantly, no fungicides or growth regulators were applied to any of the treatments.

These results represent another important step in the field validation of InLiq Agri. We are also pleased to share that we have expanded our field testing collaboration to a fourth farm, allowing us to build a broader field data set across different crops, farms and growing conditions.

Our focus remains on generating robust field evidence as we progress towards broader commercialisation.

‍

‍

Other News